ID: ALA3349390

Max Phase: Preclinical

Molecular Formula: C43H65N5O10

Molecular Weight: 812.02

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)CC(O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CC(O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C

Standard InChI:  InChI=1S/C43H65N5O10/c1-26(2)20-31(35(49)24-37(51)44-28(5)39(53)45-32(21-27(3)4)36(50)25-38(52)57-9)46-40(54)33(22-29-16-12-10-13-17-29)47-41(55)34(23-30-18-14-11-15-19-30)48-42(56)58-43(6,7)8/h10-19,26-28,31-36,49-50H,20-25H2,1-9H3,(H,44,51)(H,45,53)(H,46,54)(H,47,55)(H,48,56)/t28-,31-,32-,33-,34-,35?,36?/m0/s1

Standard InChI Key:  GDWNAJGFHLZQOE-CAYFOIAYSA-N

Associated Targets(Human)

Renin 5251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pepsin A 436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 812.02Molecular Weight (Monoisotopic): 811.4731AlogP: 3.09#Rotatable Bonds: 22
Polar Surface Area: 221.49Molecular Species: NEUTRALHBA: 10HBD: 7
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.23CX Basic pKa: CX LogP: 3.64CX LogD: 3.64
Aromatic Rings: 2Heavy Atoms: 58QED Weighted: 0.09Np Likeness Score: 0.11

References

1. Maibaum J, Rich DH..  (1988)  Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.,  31  (3): [PMID:3126296] [10.1021/jm00398a022]

Source